Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Singapore launches AI tool in 2027 to predict diabetes and cholesterol risk, enabling earlier screenings and expanded genetic cancer risk coverage starting mid-2026.
Singapore will launch an AI tool in early 2027 to predict diabetes and high cholesterol risk, identifying patients with over a 75% chance of diagnosis within three years.
The tool, used in 1,100 clinics, will recommend annual subsidized heart screenings for high-risk individuals, up from every three years.
Preventive surgeries for hereditary cancer risks will be partially covered starting mid-2026, and genetic testing will be subsidized from December 2026, with counseling provided.
AI supports, but does not replace, clinical decisions.
7 Articles
Singapur lanzará una herramienta de IA en 2027 para predecir el riesgo de diabetes y colesterol, lo que permitirá exámenes de detección más tempranos y una cobertura ampliada del riesgo genético de cáncer a partir de mediados de 2026.